ABVC BioPharma Inc (ABVC)
0.535
+0.02
(+2.88%)
USD |
NASDAQ |
Nov 13, 16:00
0.535
0.00 (0.00%)
After-Hours: 20:00
ABVC BioPharma Price to Book Value: 0.8013 for Nov. 13, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 0.8013 |
| November 12, 2024 | 0.7788 |
| November 11, 2024 | 0.788 |
| November 08, 2024 | 0.7886 |
| November 07, 2024 | 0.8124 |
| November 06, 2024 | 0.8283 |
| November 05, 2024 | 0.8539 |
| November 04, 2024 | 0.9456 |
| November 01, 2024 | 0.9885 |
| October 31, 2024 | 1.035 |
| October 30, 2024 | 1.078 |
| October 29, 2024 | 1.052 |
| October 28, 2024 | 1.108 |
| October 25, 2024 | 1.037 |
| October 24, 2024 | 1.077 |
| October 23, 2024 | 0.8537 |
| October 22, 2024 | 0.8388 |
| October 21, 2024 | 0.8088 |
| October 18, 2024 | 0.8208 |
| October 17, 2024 | 0.8188 |
| October 16, 2024 | 0.8362 |
| October 15, 2024 | 0.8793 |
| October 14, 2024 | 0.749 |
| October 11, 2024 | 0.707 |
| October 10, 2024 | 0.7108 |
| Date | Value |
|---|---|
| October 09, 2024 | 0.8048 |
| October 08, 2024 | 0.8552 |
| October 07, 2024 | 0.8245 |
| October 04, 2024 | 0.9286 |
| October 03, 2024 | 0.9548 |
| October 02, 2024 | 0.9063 |
| October 01, 2024 | 0.9586 |
| September 30, 2024 | 1.024 |
| September 27, 2024 | 1.029 |
| September 26, 2024 | 0.9885 |
| September 25, 2024 | 1.000 |
| September 24, 2024 | 1.005 |
| September 23, 2024 | 1.045 |
| September 20, 2024 | 1.042 |
| September 19, 2024 | 0.9903 |
| September 18, 2024 | 0.9885 |
| September 17, 2024 | 0.9999 |
| September 16, 2024 | 1.012 |
| September 13, 2024 | 1.040 |
| September 12, 2024 | 1.034 |
| September 11, 2024 | 1.029 |
| September 10, 2024 | 1.003 |
| September 09, 2024 | 0.9719 |
| September 06, 2024 | 0.987 |
| September 05, 2024 | 0.9751 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4293
Minimum
Oct 06 2023
198.90
Maximum
Nov 15 2019
19.56
Average
7.478
Median
Feb 14 2023
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.9398 |
| Theriva Biologics Inc | 0.0551 |
| Oragenics Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 32.39 |
| Price | 0.535 |
| Earnings Yield | -318.3% |
| Market Cap | 6.646M |